Prostacyclin synthase: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 27: Line 27:
[[Category:Enzymes]]
[[Category:Enzymes]]
{{enzyme-stub}}
{{enzyme-stub}}
<gallery>
File:Prostacyclin_synthase_2IAG_Chiang_et_al.png|Prostacyclin synthase structure from 2IAG
File:Thromboxane_synthesis.png|Thromboxane synthesis pathway
File:Eicosanoid_synthesis.svg|Eicosanoid synthesis pathways
</gallery>

Latest revision as of 03:55, 18 February 2025

Prostacyclin synthase is an enzyme that in humans is encoded by the PTGIS gene. This enzyme belongs to the family of cytochrome P450 enzymes. It plays a crucial role in the biosynthesis of prostacyclin, a potent vasodilator and inhibitor of platelet aggregation.

Function[edit]

Prostacyclin synthase converts prostaglandin H2 (PGH2) to prostacyclin (PGI2). This reaction is a part of the eicosanoid synthesis pathway, which is essential for the production of various bioactive lipids that regulate a wide range of physiological processes, including inflammation, blood flow, and platelet function.

Structure[edit]

The prostacyclin synthase enzyme is a monomer with a molecular weight of approximately 55 kDa. It contains a heme prosthetic group, which is involved in the enzyme's catalytic activity.

Clinical significance[edit]

Alterations in prostacyclin synthase activity have been associated with various diseases, including cardiovascular disease, pulmonary hypertension, and cancer. In particular, decreased prostacyclin production due to reduced prostacyclin synthase activity is a common feature of atherosclerosis and thrombosis.

See also[edit]

References[edit]

<references group="" responsive="1"></references>

Stub icon
   This article is a enzyme-related stub. You can help WikiMD by expanding it!